Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karp

Showing results (381-390 of 397) with videos related to

Pageof 40
Sort By:
Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 25, 2024
Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory InfectionsJohn Joseph, Helna Mary Baby, Joselyn Rojas Quintero, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 5, 2021
A cell-based drug delivery platform for treating central nervous system inflammationOren Levy, Veit Rothhammer, Ivan Mascanfroni, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Novel TechnologiesManish Dhyani, Nitin Joshi, Willem A Bemelman, et al.
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Journal of Medicinal Chemistry|June 15, 2016
Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular AtrophyHasane Ratni, Gary M Karp, Marla Weetall, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite AllograftsSohyung Lee, Fatih Zor, Yalcin Kulahci, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 22, 2021
Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b StudyWill J McLean, Ashley S Hinton, Jenna T J Herby, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A Mechanically Resilient Soft Hydrogel Improves Drug Delivery for Treating Post-Traumatic Osteoarthritis in Physically Active JointsNitin Joshi, Jing Yan, Mickael Dang, et al.
Pageof 40

Showing results (381-390 of 397) with videos related to

Sort By:
Pageof 40
Journal of Tissue Engineering|November 11, 2014
Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyBenjamin M Davies, Sarah Rikabi, Anna French, et al.
Advanced Materials (Deerfield Beach, Fla.)|September 25, 2024
Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory InfectionsJohn Joseph, Helna Mary Baby, Joselyn Rojas Quintero, et al.
Journal of Molecular Medicine (Berlin, Germany)|January 5, 2021
A cell-based drug delivery platform for treating central nervous system inflammationOren Levy, Veit Rothhammer, Ivan Mascanfroni, et al.
Inflammatory Bowel Diseases|May 17, 2019
Challenges in IBD Research: Novel TechnologiesManish Dhyani, Nitin Joshi, Willem A Bemelman, et al.
Journal of Medicinal Chemistry|November 26, 2013
Structure-activity relationship (SAR) optimization of 6-(indol-2-yl)pyridine-3-sulfonamides: identification of potent, selective, and orally bioavailable small molecules targeting hepatitis C (HCV) NS4BNanjing Zhang, Xiaoyan Zhang, Jin Zhu, et al.
Journal of Medicinal Chemistry|June 15, 2016
Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular AtrophyHasane Ratni, Gary M Karp, Marla Weetall, et al.
Nature Communications|December 16, 2021
Small molecule splicing modifiers with systemic HTT-lowering activityAnuradha Bhattacharyya, Christopher R Trotta, Jana Narasimhan, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite AllograftsSohyung Lee, Fatih Zor, Yalcin Kulahci, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|February 22, 2021
Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b StudyWill J McLean, Ashley S Hinton, Jenna T J Herby, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
A Mechanically Resilient Soft Hydrogel Improves Drug Delivery for Treating Post-Traumatic Osteoarthritis in Physically Active JointsNitin Joshi, Jing Yan, Mickael Dang, et al.
Pageof 40